This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,303.86 fixed-price delivery order is for the supply of QUILLIVANT XR ORAL SUSP 60ML 5MG/ML, a pharmaceutical product. The contract has a ceiling value of $7,303.86 and an ultimate completion date of December 9, 2024.
AmerisourceBergen, a for-profit organization, is the prime contractor for this award. The company maintains a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is a part of that larger IDC contract.
The contract award does not indicate any set-aside requirements, suggesting it was an open competition. As a major supplier of pharmaceutical and medical products to federal agencies, AmerisourceBergen plays a critical role in supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries through its extensive distribution capabilities.
Generated 3/7/25, 10:09 AM